A numbers game: Ribosome densities, bacterial growth, and antibiotic-mediated stasis and death

mBio

Volumn 8, Issue 1, 2017, Pages

  Levin, Bruce R ^a   McCall, Ingrid C ^a   Perrot, Véronique ^a   Weiss, Howard ^b   Ovesepian, Armen ^c   Baquero, Fernando ^d  

^a EMORY UNIVERSITY   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; MACROLIDE; RIBOSOME RNA; TETRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIOSTASIS; CELL DEATH; CELL VIABILITY; COLONY FORMING UNIT; ESCHERICHIA COLI K 12; GROWTH RATE; LYSOGENIZATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPERON; OPTICAL DENSITY; POPULATION DYNAMICS; PROTEIN SYNTHESIS; RIBOSOME; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL VIABILITY;

ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI K12; MICROBIAL VIABILITY; PROTEIN BIOSYNTHESIS; RIBOSOMES;

EID: 85014757220     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02253-16     Document Type: Article

References (52)

1. Kaufmann SH. 2008. Paul Ehrlich: founder of chemotherapy. Nat Rev Drug Discov 7:373. https://doi.org/10.1038/nrd2582.
2. Yonath A. 2005. Ribosomal crystallography: peptide bond formation, chaperone assistance and antibiotics activity. Mol Cells 20:1-16.
3. Dunkle JA, Xiong L, Mankin AS, Cate JH. 2010. Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action. Proc Natl Acad Sci U S A 107: 17152-17157. https://doi.org/10.1073/pnas.1007988107.
4. Bulkley D, Innis CA, Blaha G, Steitz TA. 2010. Revisiting the structures of several antibiotics bound to the bacterial ribosome. Proc Natl Acad Sci U S A 107:17158-17163. https://doi.org/10.1073/pnas.1008685107.
5. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810. https://doi.org/10.1016/j.cell.2007.06.049.
6. Dwyer DJ, Belenky PA, Yang JH, MacDonald IC, Martell JD, Takahashi N, Chan CT, Lobritz MA, Braff D, Schwarz EG, Ye JD, Pati M, Vercruysse M, Ralifo PS, Allison KR, Khalil AS, Ting AY, Walker GC, Collins JJ. 2014. Antibiotics induce redox-related physiological alterations as part of their lethality. Proc Natl Acad Sci U S A 111:E2100-E2109. https://doi.org/10.1073/pnas.1401876111.
7. Keren I, Wu Y, Inocencio J, Mulcahy LR, Lewis K. 2013. Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science 339:1213-1216. https://doi.org/10.1126/science.1232688.
8. Liu Y, Imlay JA. 2013. Cell death from antibiotics without the involvement of reactive oxygen species. Science 339:1210-1213. https://doi.org/10.1126/science.1232751.
9. Wright GD, Hung DT, Helmann JD. 2013. How antibiotics kill bacteria: new models needed? Nat Med 19:544-545. https://doi.org/10.1038/nm.3198.
10. Champney WS. 2006. The other target for ribosomal antibiotics: inhibition of bacterial ribosomal subunit formation. Infect Disord Drug Targets 6:377-390. https://doi.org/10.2174/187152606779025842.
11. Champney WS, Burdine R. 1996. 50S ribosomal subunit synthesis and translation are equivalent targets for erythromycin inhibition in Staphylococcus aureus. Antimicrob Agents Chemother 40:1301-1303.
12. Cundliffe E. 1987. On the nature of antibiotic binding sites in ribosomes. Biochimie 69:863-869. https://doi.org/10.1016/0300-9084(87)90213-6.
13. Hermann T. 2005. Drugs targeting the ribosome. Curr Opin Struct Biol 15:355-366. https://doi.org/10.1016/j.sbi.2005.05.001.
14. Poehlsgaard J, Douthwaite S. 2005. The bacterial ribosome as a target for antibiotics. Nat Rev Microbiol 3:870-881. https://doi.org/10.1038/nrmicro1265.
15. Lobritz MA, Belenky P, Porter CB, Gutierrez A, Yang JH, Schwarz EG, Dwyer DJ, Khalil AS, Collins JJ. 2015. Antibiotic efficacy is linked to bacterial cellular respiration. Proc Natl Acad Sci U S A 112:8173-8180. https://doi.org/10.1073/pnas.1509743112.
16. Kjeldgaard NO, Kurland CG. 1963. The distribution of soluble and ribosomal RNA as a function of growth rate. J Mol Biol 6:341-348. https://doi.org/10.1016/S0022-2836(63)80093-5.
17. Ecker RE, Schaechter M. 1963. Ribosome content and the rate of growth of Salmonella typhimurium. Biochim Biophys Acta 76:275-279. https://doi.org/10.1016/0926-6550(63)90040-9.
18. Davis BD, Luger SM, Tai PC. 1986. Role of ribosome degradation in the death of starved Escherichia coli cells. J Bacteriol 166:439-445. https://doi.org/10.1128/jb.166.2.439-445.1986.
19. Bakshi S, Siryaporn A, Goulian M, Weisshaar JC. 2012. Superresolution imaging of ribosomes and RNA polymerase in live Escherichia coli cells. Mol Microbiol 85:21-38. https://doi.org/10.1111/j.1365-2958.2012.08081.x.
20. Abel Zur Wiesch P, Abel S, Gkotzis S, Ocampo P, Engelstädter J, Hinkley T, Magnus C, Waldor MK, Udekwu K, Cohen T. 2015. Classic reaction kinetics can explain complex patterns of antibiotic action. Sci Transl Med 7:287ra73. https://doi.org/10.1126/scitranslmed.aaa8760.
21. Greulich P, Scott M, Evans MR, Allen RJ. 2015. Growth-dependent bacterial susceptibility to ribosome-targeting antibiotics. Mol Syst Biol 11: 796. https://doi.org/10.15252/msb.20145949.
22. Tritton TR. 1977. Ribosome-tetracycline interactions. Biochemistry 16: 4133-4138. https://doi.org/10.1021/bi00637a029.
23. MacKenzie FM, Gould IM. 1993. The post-antibiotic effect. J Antimicrob Chemother 32:519-537. https://doi.org/10.1093/jac/32.4.519.
24. Quan S, Skovgaard O, McLaughlin RE, Buurman ET, Squires CL. 2015. Markerless Escherichia coli rrn deletion strains for genetic determination of ribosomal binding sites. G3 (Bethesda) 5:2555-2557. https://doi.org/10.1534/g3.115.022301.
25. Bollenbach T, Quan S, Chait R, Kishony R. 2009. Nonoptimal microbial response to antibiotics underlies suppressive drug interactions. Cell 139:707-718. https://doi.org/10.1016/j.cell.2009.10.025.
26. Condon C, French S, Squires C, Squires CL. 1993. Depletion of functional ribosomal RNA operons in Escherichia coli causes increased expression of the remaining intact copies. EMBO J 12:4305-4315.
27. Stevenson BS, Schmidt TM. 2004. Life history implications of rRNA gene copy number in Escherichia coli. Appl Environ Microbiol 70:6670-6677. https://doi.org/10.1128/AEM.70.11.6670-6677.2004.
28. EUCAST. Clinical breakpoints. http://www.eucast.org/clinical_breakpoints/
29. Craig W. 2002. Pharmacodynamics of antimicrobials: general concepts and applications, p 1-22. In Nightingale C, Mutakawa T, Ambrose P (ed), Antimicrobial pharmacodynamics in theory and clinical practice. Marcel Dekker, New York, NY.
30. Sanders CC. 1988. Ciprofloxacin: in vitro activity, mechanism of action, and resistance. Rev Infect Dis 10:516-527. https://doi.org/10.1093/clinids/10.3.516.
31. Hahn FE, Sarre SG. 1969. Mechanism of action of gentamicin. J Infect Dis 119:364-369. https://doi.org/10.1093/infdis/119.4-5.364.
32. Bundtzen RW, Gerber AU, Cohn DL, Craig WA. 1981. Postantibiotic suppression of bacterial growth. Rev Infect Dis 3:28-37. https://doi.org/10.1093/clinids/3.1.28.
33. Isaksson B, Maller R, Nilsson LE, Nilsson M. 1993. Postantibiotic effect of aminoglycosides on staphylococci. J Antimicrob Chemother 32:215-222. https://doi.org/10.1093/jac/32.2.215.
34. Bulitta JB, Ly NS, Landersdorfer CB, Wanigaratne NA, Velkov T, Yadav R, Oliver A, Martin L, Shin BS, Forrest A, Tsuji BT. 2015. Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling. Antimicrob Agents Chemother 59:2315-2327. https://doi.org/10.1128/AAC.04099-14.
35. Kadurugamuwa JL, Clarke AJ, Beveridge TJ. 1993. Surface action of gentamicin on Pseudomonas aeruginosa. J Bacteriol 175:5798-5805. https://doi.org/10.1128/jb.175.18.5798-5805.1993.
36. Bryan LE, Kwan S. 1983. Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob Agents Chemother 23:835-845. https://doi.org/10.1128/AAC.23.6.835.
37. Davis BD, Chen LL, Tai PC. 1986. Misread protein creates membrane channels: an essential step in the bactericidal action of aminoglycosides. Proc Natl Acad Sci U S A 83:6164-6168. https://doi.org/10.1073/pnas.83.16.6164.
38. Davis BD. 1987. Mechanism of bactericidal action of aminoglycosides. Microbiol Rev 51:341-350.
39. Kohanski MA, Dwyer DJ, Collins JJ. 2010. How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol 8:423-435. https://doi.org/10.1038/nrmicro2333.
40. Tangy F, Moukkadem M, Vindimian E, Capmau ML, Le Goffic F. 1985. Mechanism of action of gentamicin components. Characteristics of their binding to Escherichia coli ribosomes. Eur J Biochem 147:381-386. https://doi.org/10.1111/j.1432-1033.1985.tb08761.x.
41. Borovinskaya MA, Pai RD, Zhang W, Schuwirth BS, Holton JM, Hirokawa G, Kaji H, Kaji A, Cate JH. 2007. Structural basis for aminoglycoside inhibition of bacterial ribosome recycling. Nat Struct Mol Biol 14: 727-732. https://doi.org/10.1038/nsmb1271.
42. Siibak T, Peil L, Xiong L, Mankin A, Remme J, Tenson T. 2009. Erythromycin-and chloramphenicol-induced ribosomal assembly defects are secondary effects of protein synthesis inhibition. Antimicrob Agents Chemother 53:563-571. https://doi.org/10.1128/AAC.00870-08.
43. Lancini G, Parenti F. 1982. Mechanisms of antibiotic action. In Lancini G, Parenti F (ed), Antibiotics: an integrated view. Springer-Verlag, New York, NY.
44. Chandrasekaran S, Cokol-Cakmak M, Sahin N, Yilancioglu K, Kazan H, Collins JJ, Cokol M. 2016. Chemogenomics and orthology-based design of antibiotic combination therapies. Mol Syst Biol 12:872. https://doi.org/10.15252/msb.20156777.
45. Tenson T, Mankin A. 2006. Antibiotics and the ribosome. Mol Microbiol 59:1664-1677. https://doi.org/10.1111/j.1365-2958.2006.05063.x.
46. Nemeth J, Oesch G, Kuster SP. 2015. Bacteriostatic versus bactericidal antibiotics for patients with serious bacterial infections: systematic review and meta-analysis. J Antimicrob Chemother 70:382-395. https://doi.org/10.1093/jac/dku379.
47. Pankey GA, Sabath LD. 2004. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin Infect Dis 38:864-870. https://doi.org/10.1086/381972.
48. Klappenbach JA, Saxman PR, Cole JR, Schmidt TM. 2001. rrndb: the Ribosomal RNA Operon Copy Number Database. Nucleic Acids Res 29:181-184. https://doi.org/10.1093/nar/29.1.181.
49. Stoddard SF, Smith BJ, Hein R, Roller BR, Schmidt TM. 2015. rrnDB: improved tools for interpreting rRNA gene abundance in bacteria and archaea and a new foundation for future development. Nucleic Acids Res 43:D593-D598. https://doi.org/10.1093/nar/gku1201.
50. Champney WS. 2008. Three methods to assay inhibitors of ribosomal subunit assembly. Methods Mol Med 142:63-73. https://doi.org/10.1007/978-1-59745-246-5_6.
51. Concepción-Acevedo J, Weiss HN, Chaudhry WN, Levin BR. 2015. Malthusian parameters as estimators of the fitness of microbes: a cautionary tale about the low side of high throughput. PLoS One 10:e0126915. https://doi.org/10.1371/journal.pone.0126915.
52. Löwdin E, Odenholt-Tornqvist I, Bengtsson S, Cars O. 1993. A new method to determine postantibiotic effect and effects of subinhibitory antibiotic concentrations. Antimicrob Agents Chemother 37:2200-2205. https://doi.org/10.1128/AAC.37.10.2200.